1231467

Kedrion Biopharma Inc. — FEI 3003683714

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 27, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Melville, NY (United States)